Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: An eastern cooperative oncology group trial (E4995)

Leukemia and Lymphoma

Volumn 46, Issue 1, 2005, Pages 55-61

  Cassileth, Peter A ^a   Lee, Sandra J ^b   Litzow, Mark R ^c   Miller, Kenneth B ^d   Stadtmauer, Edward A ^e   Tallman, Martin S ^f   Lazarus, Hillard M ^g   Bennett, John M ^h   Paietta, Elisabeth ⁱ   Dewald, Gordon W ^c   Rowe, Jacob M ^j  

^a UNIVERSITY OF MIAMI   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ OUR LADY OF MERCY MEDICAL CENTER   (United States)

^j TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

more..

Author keywords

AML; Autologous stem cell transplantation; High dose cytarabine; Intensive therapy

Indexed keywords

AMPHOTERICIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TOXICITY; BRAIN ABSCESS; BRAIN HEMORRHAGE; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CANDIDIASIS; CARDIOTOXICITY; CEREBELLUM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; DRUG MEGADOSE; DRUG TOLERABILITY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE OVERLOAD; HLA MATCHING; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; SINUSITIS; STOMATITIS; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 19944430945     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331283288     Document Type: Article

References (21)

1. Cassileth, P.A., Harrington, D.P., Appelbaum, F.R., Lazarus, H.M, Rowe, J.M., Paietta, E., et al. (1998) "Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission", New England Journal of Medicine, 339, 1649-1656.
2. Harousseau, J-L., Cahn, J-Y., Pignon, B., Witz, F., Milpied, N., Delain, M., et al. (1997) "Comparison of autologous bone marrow transplantation and intensive chemotherapy as post-remission therapy in adult acute myeloid leukemia", Blood, 90, 2978-2986.
3. Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., et al. (1995) "Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia", New England Journal of Medicine, 332, 217-223.
4. Burnett, A.K., Goldstone, A.H., Stevens, R.M.F., Hann, I.M., Rees, J.K.H., Gray, G.G., et al. (1998) "Randomized comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission: results of MRC AML 10 trial", Lancet, 351, 700-708.
5. Stein, A.S., O'Donnell, M.R., Chai, A., Schmidt, G.M., Nadermanee, A., Parker, P.M., et al. (1996) "In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission", Journal of Clinical Oncology, 14 2206-2216.
6. Gorin, N.C. (1998) "Autologous stem cell transplantation in acute myelocytic leukemia", Blood, 92, 1072-1090.
7. Schiller, G., Nimer, S., Gajewski, J., Lee, M., Ho, W., Territo, M., et al. (1993) "Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study", Leukemia and Lymphoma, 11, 69-77.
8. Bishop, J.F., Matthews, J.P., Young, G., Szer, J., Joshua, D.E., Dodds, A., et al. (1994) "The influence of induction chemotherapy dose and dose intensity on the duration of remission of acute myeloid leukemia", Leukemia and Lymphoma, 15, 79-84.
9. Bishop, J.F., Matthews, J.P., Young, G.A., Szer, J., Gillett, A., Joshua, D., et al. (1996) "A randomized study of high-dose cytarabine in induction in acute myeloid leukemia", Blood, 87 1710-1717.
10. Bishop, J.F., Matthews, J.P., Young, G.A.R., Bradstock, K. and Lowenthal, R.M. on behalf of the ALSG (1998) "Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group". Leukemia and Lymphoma, 28, 315-327.
11. Weick, J.K., Kopecky, K.J., Appelbaum, F.R., Head, D.R., Kingsbury, L.L., Balcerzak, S.P., et al. (1996) "A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Study Group", Blood, 88, 2841-2851.
12. Lowenthal, R.M., Bradstock, K.F., Matthews, J.P., Bishop, J.F., Juneja, S., Cobcroft, R., et al. (1999) "A Phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia", Leukemia and Lymphoma, 34, 501-510.
13. Buchner, T., Hiddemann, W., Wormann, B., Loffler, H., Gassmann, W., Haferlach, T., et al. (1999) "Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the German AML Cooperative Group", Blood, 93(12), 4116-4124.
14. Phillips, G.L., Reece, D.E., Shepherd, J.D., Barnett, M.J., Brown, D.A., Frei-Lahr, D.A., et al. (1991) "High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults", Blood, 77 1429-1435.
15. Mitus, A.J., Miller, K.B., Schenkein, D.P., Ryan, H.F., Parson, S.K., Wheeler, C., et al. (1995) "Improved survival for patients with acute myelogenous leukemia", Journal of Clinical Oncology, 13, 560-569.
16. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., et al. (1994) "Intensive postremission chemotherapy in adults with acute myeloid leukemia", New England Journal of Medicine, 331, 896-903.
17. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., et al. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", Journal of Clinical Oncology 8, 813-819.
18. Kaplan, E.L. and Meier, R. (1958) "Nonparametric estimation from incomplete observation", Journal of the American Statistical Association, 53, 457-481.
19. Petersdorf, S., Rankin, C., Terebolo, H., Head, D. and Appelbaum, F. (1998) "A phase II study of standard dose daunomycin and cytosine arabinoside (ARA-C) with High Dose ARA-C induction therapy followed by sequential high dose ARA-C consolidation for adults with previously untreated acute myelogenous leukemia: a SouthWest Oncology Group Study (SWOG 9500)", Proceedings of the American Society of Clinical Oncology, 17, 15a.
20. Cahn, J-Y., Labopin, M., Sierra, J., Blaise, D., Reiffers, J., Ferrant, A., et al. (2000) "No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission", British Journal of Haematology, 110, 308-314.
21. Tallman, M.S., Rowlings, P.A., Milone, G., Zhang, M.J., Perez, W.S., Weisdorf, D., et al., (2000) "Effect of postremission chemotherapy from human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission", Blood, 96, 1254-1258.